Non-vitamin K Oral Anticoagulants and Anti-seizure Medications: A Retrospective Cohort Study

Non-vitamin K Oral Anticoagulants and Anti-seizure Medications: A Retrospective Cohort Study

Purpose: Concerns of drug–drug interactions (DDIs) between anti-seizure medications (ASMs) and non-vitamin K oral anticoagulants (NOACs) have emerged in recent case reports and guidelines. Theoretically, the induction of hepatic cytochrome P450 3A4 (CYP3A4) enzyme and permeability glycoprotein (P-GP...

Full description

Bibliographic Details
Main Authors:	Chen-Jui Ho, Shih-Hsuan Chen, Chih-Hsiang Lin, Yan-Ting Lu, Che-Wei Hsu, Meng-Han Tsai
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Neurology
Subjects:	epilepsy ASM drug–drug interaction stroke NOAC
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2020.588053/full

Similar Items

Safety of concomitant treatment with Non-Vitamin K Oral Anticoagulants and SSRI/SNRI antidepressants
by: Boguta Piotr, et al.
Published: (2018-12-01)

EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS FOR PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION
by: S. K. Zyryanov, et al.
Published: (2017-07-01)

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants
by: Raphael Chinedu Anakwue
Published: (2020-01-01)

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Impact of Reduced-Dose Nonvitamin K Antagonist Oral Anticoagulants on Outcomes Compared to Warfarin in Korean Patients with Atrial Fibrillation: A Nationwide Population-Based Study
by: Sola Han, et al.
Published: (2021-08-01)

Efficacy and safety outcomes in novel oral anticoagulants versus vitamin-K antagonist on post-TAVI patients: a meta-analysis
by: Hongbin Liang, et al.
Published: (2020-06-01)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
by: Yi-Hsin Chan, et al.
Published: (2020-05-01)

Rates of Intracranial Hemorrhage in Mild Head Trauma Patients Presenting to Emergency Department and Their Management: A Comparison of Direct Oral Anticoagulant Drugs with Vitamin K Antagonists
by: Gabriele Savioli, et al.
Published: (2020-06-01)

Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation
by: Giuseppe Patti, et al.
Published: (2018-06-01)

Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
by: Emma Kirstine Laugesen, et al.
Published: (2019-11-01)

Fatal consequences of synergistic anticoagulation
by: Sen P, et al.
Published: (2018-05-01)

Is Cenobamate the Breakthrough We Have Been Wishing for?
by: Nicola Specchio, et al.
Published: (2021-08-01)

Cardiovascular risks and bleeding with non-vitamin K antagonist oral anticoagulant versus warfarin in patients with type 2 diabetes: a tapered matching cohort study
by: Dahai Yu, et al.
Published: (2020-10-01)

Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications
by: Stefan Wolking, et al.
Published: (2021-06-01)

Major bleeding risk with non‐vitamin K antagonist oral anticoagulant vs. aspirin in heart failure: network meta‐analysis
by: Wen‐Yi Huang, et al.
Published: (2020-12-01)

The Pharmacoresistant Epilepsy: An Overview on Existant and New Emerging Therapies
by: Antonella Fattorusso, et al.
Published: (2021-06-01)

Plasma Rivaroxaban Level to Identify Patients at Risk of Drug Overexposure: Is a Single Measurement of Drug Level Reliable?
by: Krishnan Shyamkumar, et al.
Published: (2021-01-01)

Frequency of atrial thrombus formation in patients with atrial fibrillation under treatment with non-vitamin K oral anticoagulants in comparison to vitamin K antagonists: a systematic review and meta-analysis
by: Stefan Reers, et al.
Published: (2018-10-01)

Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults – a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing
by: Christina Sommerauer, et al.
Published: (2017-10-01)

Perioperative management of anticoagulant therapy
by: Wagner Johanna, et al.
Published: (2019-12-01)

Direct Oral Anticoagulants and Timing of Hip Fracture Surgery
by: Seth M. Tarrant, et al.
Published: (2020-07-01)

Trends in anticoagulant prescribing: a review of local policies in English primary care
by: Katherine H. Ho, et al.
Published: (2020-04-01)

Inclusion in the World Health Organization Model List of Essential Medicines of Non-Vitamin K Anticoagulants for Treatment of Non-Valvular Atrial Fibrillation: A Step Towards Reducing the Burden of Cardiovascular Morbidity and Mortality
by: Ezequiel J. Zaidel, et al.
Published: (2020-08-01)

Diagnosis and Treatment for embolic stroke of undetermined source: Consensus statement from the Taiwan stroke society and Taiwan society of cardiology
by: Li-Kai Tsai, et al.
Published: (2021-01-01)

When should we obtain a routine EEG while managing people with epilepsy?
by: Tasneem F. Hasan, et al.
Published: (2021-01-01)

Pre-Stroke Statin Therapy Improves In-Hospital Prognosis Following Acute Ischemic Stroke Associated with Well-Controlled Nonvalvular Atrial Fibrillation
by: Paweł Wańkowicz, et al.
Published: (2021-07-01)

Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Mohammed A Kubas, et al.
Published: (2020-01-01)

Atrial fibrillation and coronary artery disease: a review on the optimal use of oral anticoagulants
by: Pier Paolo Bocchino, et al.
Published: (2021-09-01)

Crosstalk Between Signaling Pathways Involved in the Regulation of Airway Smooth Muscle Cell Hyperplasia
by: Hui Min Yap, et al.
Published: (2019-10-01)

Suicidal drug overdose following stroke in elderly patients: a retrospective population-based cohort study
by: Chang CH, et al.
Published: (2018-02-01)

On the Use of Mathematical Models for Wastewater Treatment: A Review and Analysis of Activated Sludge Models ASM1 and ASM3
by: Başak SAVUN-HEKİMOĞLU
Published: (2021-03-01)

Use of Novel oral anticoagulants (NOACs) in patients with risk of stroke in non valvular Atrial Fibrillation (AF)
by: Fawad Farooq, et al.
Published: (2017-12-01)

THE PROBLEM OF AGGRAVATION OF EPILEPTIC SEIZURES DURING THERAPY WITH ANTIEPILEPTIC DRUGS
by: K. Yu. Mukhin, et al.
Published: (2015-04-01)

Warfarin versus direct oral anticoagulants for treating left ventricular thrombus: a systematic review and meta-analysis
by: Tarun Dalia, et al.
Published: (2021-02-01)

Analysis of the Introduction in Clinical Practice of New Oral Anticoagulants in Local Health Agency BT: Translation of the Clinical Trial Data to a Local Health Care Area
by: Gianluca Grimaldi, et al.
Published: (2021-02-01)

Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study
by: Sadık Volkan Emren, et al.
Published: (2018-05-01)

Is the use of warfarin becoming obsolete?
by: Tarek Haykal, et al.
Published: (2021-05-01)

Antithrombotic treatment pattern in newly diagnosed atrial fibrillation patients and 2-year follow-up results for dabigatran-treated patients in the Africa/Middle-East Region: Phase II results from the GLORIA-AF registry program
by: Rabih R. Azar, et al.
Published: (2021-06-01)

Drug-induced audiogenic seizure and its suppression
by: Wong, Franklin Chiu-Leung
Published: (1980)

New Compounds against <i>Leishmania infantum</i> from <i>Eremurus persicus</i>
by: Emanuela Martino, et al.
Published: (2019-08-01)